<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140004156A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140004156</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13516925</doc-number><date>20101210</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><priority-claims><priority-claim sequence="01" kind="national"><country>GB</country><doc-number>0922143.3</doc-number><date>20091218</date></priority-claim><priority-claim sequence="02" kind="national"><country>GB</country><doc-number>1009307.8</doc-number><date>20100603</date></priority-claim></priority-claims><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>K</subclass><main-group>16</main-group><subgroup>28</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>12</class><subclass>N</subclass><main-group>15</main-group><subgroup>113</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>K</subclass><main-group>16</main-group><subgroup>28</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc><further-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>12</class><subclass>N</subclass><main-group>15</main-group><subgroup>1138</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></further-cpc></classifications-cpc><classification-national><country>US</country><main-classification>424400</main-classification><further-classification>5303879</further-classification><further-classification>536 245</further-classification><further-classification>536 231</further-classification><further-classification>4353201</further-classification><further-classification>435325</further-classification><further-classification>435375</further-classification><further-classification>4241391</further-classification><further-classification>514 44  A</further-classification><further-classification>536 2353</further-classification><further-classification>435331</further-classification></classification-national><invention-title id="d0e79">BIOLOGICAL INHIBITORS OF ROR1 CAPABLE OF INDUCING CELL DEATH</invention-title><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Mellstedt</last-name><first-name>Hakan</first-name><address><city>Stockholm</city><country>SE</country></address></addressbook><residence><country>SE</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>Rabbani</last-name><first-name>Hodjattallah</first-name><address><city>Stockholm</city><country>SE</country></address></addressbook><residence><country>SE</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>Teige</last-name><first-name>Ingrid</first-name><address><city>Lund</city><country>SE</country></address></addressbook><residence><country>SE</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Mellstedt</last-name><first-name>Hakan</first-name><address><city>Stockholm</city><country>SE</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Rabbani</last-name><first-name>Hodjattallah</first-name><address><city>Stockholm</city><country>SE</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Teige</last-name><first-name>Ingrid</first-name><address><city>Lund</city><country>SE</country></address></addressbook></inventor></inventors></us-parties><pct-or-regional-filing-data><document-id><country>WO</country><doc-number>PCT/EP2010/007524</doc-number><kind>00</kind><date>20101210</date></document-id><us-371c124-date><date>20130301</date></us-371c124-date></pct-or-regional-filing-data></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The invention relates to antibodies and siRNA molecules for inducing cell death by the specific binding of ROR1, domains thereof of nucleotide molecules encoding ROR1. There are also provided methods involving and uses of the antibodies and siRNA molecules of the invention.</p></abstract></us-patent-application>